[EN] COMPOUNDS WITH ANTIBACTERIAL ACTIVITY AGAINST CLOSTRIDIUM<br/>[FR] COMPOSÉS DOTÉS D'UNE ACTIVITÉ ANTIBACTÉRIENNE DIRIGÉE CONTRE CLOSTRIDIUM
申请人:ELANCO ANIMAL HEALTH IRELAND
公开号:WO2012017030A1
公开(公告)日:2012-02-09
The present invention is related to novel compounds of formula (I) having antibacterial activity against Clostridium bacteria, in particular Clostridium perfringens, pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds.
COMPOUNDS WITH ANTIBACTERIAL ACTIVITY AGAINST CLOSTRIDIUM
申请人:Guillemont Jerome Emile Georges
公开号:US20130109694A1
公开(公告)日:2013-05-02
The present invention is related to novel compounds of formula (I) having antibacterial activity against
Clostridium
bacteria, in particular
Clostridium perfringens
, pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds.
Substituted Phenylether-Thienopyridone Compounds With Antibacterial Activity
申请人:GUILES JOSEPH
公开号:US20080227808A1
公开(公告)日:2008-09-18
Novel bicyclic heteroaromatic compounds are provided that are inhibitors of bacterial methionyl tRNA synthetase (MetRS). Compounds of the invention generally have a left hand side phenylether constituent and a right hand side thienopyridone constituent. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, particularly as anti-
Clostridium difficile
agents.
Enantiomeric Compounds With Antibacterial Activity
申请人:GUILES Joseph
公开号:US20080108651A1
公开(公告)日:2008-05-08
Novel compounds in enantiomeric excess that are inhibitors of bacterial methionyl synthetase (MetRS) are disclosed. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, and in particular their use in therapy for
Clostridium difficile
infection.
Substituted Thienopyridone Compounds With Antibacterial Activity
申请人:GUILES Joseph
公开号:US20080146609A1
公开(公告)日:2008-06-19
Novel bicyclic heteroaromatic compounds are provided that are inhibitors of bacterial methionyl tRNA synthetase (MetRS). Compounds of the invention generally have a left hand side chroman group or left hand side tetrahydroquinoline group and a right hand side thienopyridone group. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, particularly as anti-
Clostridium difficile
agents.